PWM
IMRX icon

Palumbo Wealth Management’s Immuneering IMRX Stock Holding History

Palumbo Wealth Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.4K Sell
18,670
-44,603
-70% -$229K 0.02% 220
2025
Q4 		$416K Buy
63,273
+14,221
+29% +$91.3K 0.1% 140
2025
Q3 		$343K Buy
+49,052
New +$255K 0.11% 120

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Palumbo Wealth Management's IMRX Position: Q1 2026 in Review

Palumbo Wealth Management reduced its Immuneering (IMRX) stake by 70% in Q1 2026, selling an estimated $229K and leaving 18,670 shares worth $98.4K. The position accounts for 0.02% of the portfolio, ranked #220.

Palumbo Wealth Management first reported a position in IMRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $416K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Palumbo Wealth Management held 18,670 shares of Immuneering worth $98.4K as of Q1 2026.
  • Palumbo Wealth Management sold 44,603 Immuneering shares in Q1 2026, an estimated $229K.
  • Immuneering made up 0.02% of Palumbo Wealth Management's portfolio in Q1 2026, its #220 holding.
  • Palumbo Wealth Management first reported a position in Immuneering in Q3 2025 and has held it in 3 quarters since.
  • Palumbo Wealth Management's Immuneering position peaked at $416K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.